ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • back pain and population studies
  • back pain and posture
  • Back pain and psoriatic arthritis
  • back pain and quality of life
  • Back pain and spondylarthritis
  • back pain and spondylarthropathy
  • Back pain and systemic lupus erythematosus (SLE)
  • Back pain and ultrasound
  • Back surgery
  • back surgery and healthcare reform
  • Bacterial infections
  • bacterial infections and infection
  • bacterial infections and oral
  • bacterial infections and rheumatoid arthritis (RA)
  • Bacterial infections and systemic lupus erythematosus (SLE)
  • bacterial infections and uveitis
  • bacterial infections and vasculitis
  • BAFF
  • BAFF and arthritis
  • BAFF and cytokines
  • BAFF and IL-6
  • BAFF and lymphocytes
  • BAFF and pregnancy
  • BAFF and rheumatoid arthritis (RA)
  • BAFF and Sjogren's syndrome
  • BAFF and SLE
  • BAFF and systemic lupus erythematosus (SLE)
  • bariatric and biomarkers
  • bariatric and psoriatic arthritis
  • Bariatric Surgery
  • baricitinib
  • barriers
  • baseline kidney biopsy
  • basic calcium phosphate
  • basic research
  • basic research and autoimmunity
  • Basic research and rheumatoid arthritis (RA)
  • Basic Science
  • Basic Science and B cells
  • Basic Science and systemic lupus erythematosus (SLE)
  • BDCAF
  • bDMARDs
  • Behçet's Syndrome
  • Behavioral strategies
  • Behavioral strategies and osteoarthritis
  • Behavioral strategies and rheumatoid arthritis (RA)
  • Behcet's disease
  • Behcet's syndrome
  • Behçet's Syndrome
  • Behcet's syndrome and adipocytokines
  • Behcet's syndrome and amyloidosis
  • Behcet's syndrome and autoantibodies
  • Behcet's syndrome and chemokines
  • Behcet's syndrome and Clinical
  • Behcet's syndrome and cluster analysis
  • Behcet's syndrome and Disease Activity
  • Behcet's syndrome and familial Mediterranean fever
  • Behcet's syndrome and functions
  • Behcet's syndrome and genetics
  • Behcet's syndrome and genomics
  • Behcet's syndrome and infliximab
  • Behcet's syndrome and interleukins (IL)
  • Behcet's syndrome and KIR (Killer Ig like receptor)
  • Behcet's syndrome and macrophage
  • Behcet's syndrome and medication
  • Behcet's syndrome and metabolomics
  • Behcet's syndrome and microbiome
  • Behcet's syndrome and outcome measures
  • Behcet's syndrome and outcomes
  • Behcet's syndrome and patient questionnaires
  • Behcet's syndrome and pediatric rheumatology
  • Behcet's syndrome and polymorphism
  • Behcet's syndrome and proteomics
  • Behcet's syndrome and quality of life
  • Behcet's syndrome and Redox Balance
  • Behcet's syndrome and spondylarthropathy
  • Behcet's syndrome and thrombosis
  • Behcet's syndrome and tocilizumab
  • Behcet's syndrome and treatment
  • Behcet's syndrome and uveitis
  • Behcet's syndrome and vaccines
  • Behcet's syndrome and vasculitis
  • Behcet's syndrome and Work Disability
  • beliefs and adherence
  • belimumab
  • belimumab and B cell targeting
  • belimumab and clinical trials
  • Belimumab and corticosteroids
  • belimumab and flow cytometry
  • belimumab and health disparities
  • belimumab and immunoglobulin (IG)
  • belimumab and juvenile SLE
  • belimumab and meta-analysis
  • belimumab and outcomes
  • belimumab and pharmacokinetics
  • belimumab and steroids
  • belimumab and synovial cells
  • belimumab and systemic lupus erythematosus (SLE)
  • belimumab and treatment
  • belimumab and vaccines
  • Benchmarking tools
  • benchmarking tools and Knee
  • Benefits
  • benzodiazepines and adults
  • Best Practice
  • Best practices
  • best practices and social work
  • beta-2 glycoprotein I
  • beta-endorphin and neurotensin
  • Bias and rheumatic disease
  • Big data
  • big data and antibodies
  • big data and data analysis
  • big data and death
  • big data and diagnosis
  • big data and diagnostic criteria
  • big data and epidemiologic methods
  • big data and health care cost
  • big data and neutrophils
  • big data and quality of life
  • big data and safety
  • big data and salivary gland
  • BILAG
  • bile and hepatic disorders
  • Billing
  • Bio-naïve Active Psoriatic Arthritis and Skin and Nail Psoriasis
  • bioequivalence
  • bioinformatic and Gene siganture
  • Bioinformatics
  • bioinformatics and autoimmunity
  • bioinformatics and Basic Science
  • bioinformatics and biomarkers
  • bioinformatics and diagnosis
  • bioinformatics and Electronic Health Record
  • bioinformatics and interferons
  • bioinformatics and networking
  • bioinformatics and pathogenesis
  • bioinformatics and population studies
  • bioinformatics and rheumatoid arthritis (RA)
  • bioinformatics and steroids
  • biologic
  • Biologic agents
  • Biologic agents and adherence
  • Biologic agents and adverse events
  • Biologic agents and ankylosing spondylitis (AS)
  • Biologic agents and axial spondyloarthritis
  • Biologic agents and biomarkers
  • Biologic agents and biosimilars
  • Biologic agents and chikungunya
  • Biologic agents and Churg-Strauss syndrome
  • Biologic agents and Clinical Response
  • Biologic agents and clinical trials
  • Biologic agents and computed tomography (CT)
  • Biologic agents and Disease Activity
  • Biologic agents and disease-modifying antirheumatic drugs
  • Biologic agents and inflammation
  • Biologic agents and Janus kinase (JAK)
  • Biologic agents and lipids
  • Biologic agents and NONI
  • Biologic agents and observation
  • Biologic agents and patient questionnaires
  • Biologic agents and prognosis
  • Biologic agents and PROM
  • Biologic agents and psoriatic arthritis
  • Biologic agents and pulmonary complications
  • Biologic agents and remission
  • Biologic agents and rheumatoid arthritis
  • Biologic agents and rheumatoid arthritis (RA)
  • Biologic agents and spondylarthritis
  • Biologic agents and statins
  • Biologic agents and systemic vasculitides
  • Biologic agents and treatment
  • Biologic agents and tuberculosis
  • Biologic agents and uveitis
  • Biologic DMARDs
  • Biologic drugs
  • biologic drugs and biologic response modifiers
  • biologic drugs and certolizumab pegol
  • biologic drugs and clinical practice
  • biologic drugs and clinical trials
  • biologic drugs and drug toxicity
  • biologic drugs and fever
  • biologic drugs and funding
  • Biologic drugs and hepatitis
  • biologic drugs and immune response
  • biologic drugs and inflammatory arthritis
  • biologic drugs and injection fear
  • Biologic drugs and juvenile idiopathic arthritis (JIA)
  • biologic drugs and liver chemistry
  • biologic drugs and longitudinal studies
  • biologic drugs and lupus nephritis
  • biologic drugs and patient preferences
  • biologic drugs and pediatric rheumatology
  • Biologic drugs and psoriatic arthritis
  • Biologic drugs and quality of life
  • biologic drugs and randomized trials
  • biologic drugs and registries
  • Biologic drugs and rheumatoid arthritis
  • biologic drugs and rheumatoid arthritis (RA)
  • biologic drugs and spondylarthritis
  • First |
  • « Previous Page
  • 3
  • 4
  • 5
  • 6
  • 7
  • [8]
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences